Atlas Trials

Gastroenteropancreatic NEC (GEP NEC)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastroenteropancreatic NEC (GEP NEC)

RecordFirmDate
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) (NCT07488923)Moonlight Bio, Inc2026-06-01
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors (NCT07278479)Molecular Partners AG2026-05-18

Track Gastroenteropancreatic NEC (GEP NEC) automatically

Every clearance here is in the API, with alerts when new ones post.